France OKays new jab

PARIS: The French national authority of health (HAS) officially approved the Nuvaxovid vaccine for Covid-19 on Friday (Saturday in Manila). “The data from various studies show the high efficiency of the Nuvaxovid vaccine against the symptomatic forms of Covid-19 (nearly 90 percent), and in particular against severe forms with nearly 100 percent efficiency,” HAS said in a statement. Nuvaxovid, manufactured by American biotechnology company Novavax, is suitable for people over the age of 18, with a delay between doses of three weeks, HAS said.